Localization of E-cadherin and Vimentin in Mucosal Ulcer Healing Treated by Vitis Vinifera Seeds Oil in Rat Model
DOI:
https://doi.org/10.5195/d3000.2025.847Keywords:
Vitis vinifera seed oil (GSO), Mucosal ulcer, Vimentin, E-cadherin, Rats, Healing, EMTAbstract
Objective: The anti-inflammatory components generated by Vitis vinifera (Grape) seeds oil (GSO) help reduce inflammation and accelerate the healing process when applied topically to an ulcer. The current study aimed to assess the expression of E-cadherin and Vimentin during oral ulcer healing treated by GSO.
Materials and Methods: Twenty-four albino male rats (350–450 g) were used for this study. The rats were slaughtered on the 5th and 10th days after an ulcer induction on either their left or right cheek mucosa. The rats in the control group received sterile distilled water, whereas those in the experimental group received GSO for ulcers treatment. The tissue samples were subsequently utilized for histological and immunohistochemical investigations of E-cadherin and Vimentin.
Results: Compared with the control group, the GSO-treated ulcer group presented significantly higher expression of E-cadherin and Vimentin at days 5 and 10 than the control group, with some evidence of epithelial-mesenchymal transition (EMT) at 5 days in both groups.
Conclusion: With the limitation of this study, GS may accelerate the healing of mucosal ulcers, as demonstrated by increased expression of E-cadherin and Vimentin.
Clinical relevance: GSO can be used as a topical herbal modality for mucosal ulcer healing.
References
References
Abd, S.S. and AL-Ghaban, N,M.H..The Epidermal Growth Factor Receptor Expression in Leptin- Treated Traumatic Oral Ulcer in Rats. JGPT. 2020 10.13140/RG.2.2.33703.78249.
Ozgok Kangal MK, Regan JP..Wound Healing. StatPearls Publishing; Treasure Island (FL): 2023,May 1.
Andrea Ardid-Ruiz, András Harazin, Lilla Barna, Fruzsina R. Walter, Cinta Bladé, Manuel Suárez, Maria A. Deli, Gerard Aragonès, the effects of Vitis vinifera L. phenolic compounds on a blood-brain barrier culture model: Expression of leptin receptors and protection against cytokine-induced damage,Journal of Ethnopharmacology,Volume 247,2020,112253,ISSN 0378-8741,https://doi.org/10.1016/j.jep.2019.112253.
AbdAlrazaq, M.H., &Al-Ghaban, N.M.H.Immunohistochemical Localization Of Bone Morphogenic Protein-2 In Extracted Tooth Socket Treated By Local Application Of Grape Seeds Oil In Rabbits. Biochemical and Cellular Archives. 20.10.35124/bca.2020.20.1.581.
Bellili, S., Jazi, S., Nasr, S., et al. Grape Seed Oil: Chemical Composition, Biological Properties And Health Benefits.2018 Jan, 978-153613561-9;978-153613560-2.
Garavaglia J, Markoski MM, Oliveira A, Marcadenti A. Grape Seed Oil Compounds: Biological and Chemical Actions for Health. Nutr Metab Insights. 2016 Aug 16;9:59-64. doi: 10.4137/NMI.S32910. PMID: 27559299; PMCID: PMC4988453.
Abe-Yutori, M., Chikazawa, T., Shibasaki, K., & Murakami, S.. Decreased expression of E-cadherin byPorphyromonas gingivalis-lipopolysaccharide attenuates epithelial barrier function. Journal of Periodontal Research, (2016) 52(1), 42–50. doi:10.1111/jre.12367.
Grabenstetter A, Mohanty AS, Rana S, Zehir A, Brannon AR, D'Alfonso TM, DeLair DF, Tan LK, Ross DS. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations. Hum Pathol. 2020 Aug;102:44-53. Doi 10.1016/j.humpath.2020.06.002. Epub 2020 Jun 26. PMID: 32599083; PMCID: PMC7484442.
Arrindell J, Desnues B. Vimentin: from a cytoskeletal protein to a critical modulator of immune response and a target for infection. Front Immunol. 2023 Jul 5;14:1224352. doi: 10.3389/fimmu.2023.1224352. PMID: 37475865; PMCID: PMC10354447.
Ramos I, Stamatakis K, Oeste CL, Pérez-Sala D. Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections. Int J Mol Sci. 2020 Jun 30;21(13):4675. doi: 10.3390/ijms21134675. PMID: 32630064; PMCID: PMC7370124.
Kalluri R, Weinberg RA. The basics of epithelial–mesenchymal transition. J Clin Invest. 2009 Jun;119(6):1420-8. doi: 10.1172/JCI39104. Erratum in: J Clin Invest. 2010 May 3;120(5):1786. PMID: 19487818; PMCID: PMC2689101.
Haensel D, Dai X. Epithelial-to-mesenchymal transition in cutaneous wound healing: Where we are and where we are heading. Dev Dyn. 2018 Mar;247(3):473-480. doi: 10.1002/dvdy.24561. Epub 2017 Sep 5. PMID: 28795450; PMCID: PMC5809211.
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. Animal research: reporting in vivo experiments: the ARRIVE guidelines. British journal of pharmacology. .(2010) 160(7):1577-9.
Ma ZF, Zhang H. Phytochemical Constituents, Health Benefits, and Industrial Applications of Grape Seeds: A Mini-Review. Antioxidants. 2017; 6(3):71. https://doi.org/10.3390/antiox6030071.
Giroux MC, Hélie P, Burns P, Vachon P. Anesthetic and pathological changes following high doses of ketamine and xylazine in Sprague Dawley rats. Exp Anim.64(3):253-60. Doi: 10.1538/expanim.14-0088. Epub 2015 Mar 27. PMID: 25818316; PMCID: PMC4547998.
Wang X, Yan L, Tang Y, He X, Zhao X, Liu W, Wu Z, Luo G. Anti-inflammatory effect of HGF responses to oral traumatic ulcers using an HGF-Tg mouse model. Exp Anim.May 20;71(2):204-213. doi: 10.1538/expanim.21-0141. Epub 2021 Nov 25. PMID:34819402; PMCID: PMC9130041.
Mohamed, I. F., Ghani, B. A., & Fatalla, A. A. Histological evaluation of the effect of local application of Punica granatum seed oil on bone healing. International Journal of Biomaterials, 2022, 426658.
Dantas, T. S., de Barros Silva, P. G., Verde, M. E. Q. L., Júnior, A., de, L. R., Cunha, M., do, S. S., Mota, M. R. L., & Sousa, F. B. Role of inflammatory markers in the prognosis of oral squamous cell carcinoma. Asian Pacific Journal of Cancer Prevention: APJCP, (2019)20(12), 3635.
Takahiro, T., Sushil, K., Rohan, N., B., Vahid, A., Guillaume, T., Hwan, C., Ariel, B., Kawashima, R., Gina, C., David S., Daniel, R., Molly, F., Eric R., Lei, Z., Elizabeth, M., Patrick, L., Adam , A. , Margolin, M., Joe, W., Gray, P., W. Flint and Lisa M. Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed TumorImmune Complexity Associated with Poor Prognosis. CoussensCell Reports(2017)19, 203–217.
Rizzardi, A., Johnson, A., Vogel, R., Pambuccian, S., Henriksen, J., Skubitz, A., Metzger, G, Schmechel, S. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagnostic Pathology, (2012). 7:42.
AL-Ghaban NM, Jasem GH. (2020). Histomorphometric evaluation of the effects of local application of red clover oil (trifolium pretense) on bone healing in rats. J Bagh Coll Dent [Internet]. Jun. 15 [cited 2024 Sep. 29];32(2):26-31.
Abed, A. & Al-Ghaban, N.M.H. Acceleration of Ulcer Healing by Local Application of Myrrh Oil: An Experimental Study. Al- Anbar Medical Journal. (2023)10.33091/amj.2023.140046.1131.
Bandyopadhyay, C., Schecterson, L., & Gumbiner, B. M. E-cadherin activating antibodies limit barrier dysfunction and inflammation in mouse inflammatory bowel disease. Tissue Barriers, (2021).9(4).
Cavalcante GM, Sousa de Paula RJ, Souza LP, et al. Experimental model of traumatic ulcer in the cheek mucosa of rats. Acta Cir Bras. 2011 Jun;26(3):227-34. doi: 10.1590/s0102- 86502011000300012. PMID: 21537526.
Silvan JM, Gutierrez-Docio A, Guerrero-Hurtado E, et al. Pre-Treatment with Grape Seed Extract Reduces Inflammatory Response and Oxidative Stress Induced by Helicobacter pylori Infection in Human Gastric Epithelial Cells. Antioxidants (Basel). (2021)Jun 11;10(6):943. doi: 10.3390/antiox10060943. PMID: 34208004; PMCID: PMC8230724.
Burandt E, Lübbersmeyer F, Gorbokon N, Büscheck F, Luebke AM, Menz A, Kluth M, Hube- Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Jacobsen F, Lebok P, Clauditz TS, Sauter G, Simon R, Uhlig R, Wilczak W, Steurer S, Minner S, Krech R, Dum D, Krech T, Marx AH, Bernreuther C. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors. Biomark Res. (2021). Jun 5;9(1):44. doi: 10.1186/s40364- 021-00299-4. PMID: 34090526; PMCID: PMC8180156.
Sridevi U, Ja in A, N ag al am i V, K u m ar U V, G oya l S. Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas. Eur J Dent 2015;9:364-72.
Ostrowska-Podhorodecka Z, Ding I,Norouzi M and McCulloch CA.Impact of Vimentin on Regulation of Cell Signaling and Matrix Remodeling.Front. Cell Dev. (2022) Biol.10:869069.doi:10.3389/fcell.2022.869069
Kuwahara H, Tosa M, Egawa S, Murakami M, Mohammad G, Ogawa R. Examination of Epithelial Mesenchymal Transition in Keloid Tissues and Possibility of Keloid Therapy Target. Plast Reconstr Surg Glob Open. 2016. Nov 28;4(11):e1138. doi: 10.1097/GOX.0000000000001138. PMID: 27975033; PMCID: PMC5142499.
Chai, J., Norng, M., Modak, C. et al.CCN1 induces a reversible epithelial– mesenchymal transition in gastric epithelial cells. Lab Invest 90, 1140–1151. https://doi.org/10.1038/labinvest.2010.101
Sawant, S., Vaidya, M., Chaukar, D., Alam, H., Dmello, C., Gangadaran, P., … D’Cruz, A. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas. Oral Diseases, (2013). 20(5), 453–465. doi:10.1111/odi.1215.
Baum B, Settleman J, Quinlan MP Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol(2008) 19:294–308.
Lee JM, Dedhar S, Kalluri R, Thompson EW The epithelial–mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol (2006) 172: 973–981.
Tian, M.Y. and Li, Y. The Expression of E-Cadherin and Vimentin in Non-Small Cell Lung Cancer and Their Correlation with Epithelial–Mesenchymal Transition (EMT). Journal of Biosciences and Medicines, (2018). 6, 1-8.
Yuksel H, Ocalan M, Yilmaz O. E-Cadherin: An Important Functional Molecule at Respiratory Barrier Between Defense and Dysfunction. Front Physiol. (2021). Oct 4;12:720227. doi: 10.3389/fphys. 720227. PMID: 34671272; PMCID: PMC852104.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Russol Faik, Nada M.H. Al-Ghaban

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Revised 7/16/2018. Revision Description: Removed outdated link.